Since 2023, the pharmaceutical industry operating in Europe has faced an unprecedented challenge related to drug shortages.

Sheffield-headquartered aquaculture biotechnology company, Benchmark, has agreed to sell its genetics business area to Novo ...

After six straight quarters in which Eli Lilly or Novo Nordisk achieved the highest year-over-year revenue growth among the ...

In early UK corporate news, miner Anglo American and fish farming company Benchmark Holdings announced disposals. DIY retail chain operator Kingfisher trimmed the top of its profit outlook range, as ...

Novo Nordisk will report the topline results from the REDEFINE-1 trial of CagriSema in obese patients before the end of the ...

Pharmaceutical company Novo Nordisk has launched its mega-popular weight-loss drug Wegovy in China — but for a tiny fraction ...

We recently published a list of 8 Most Promising Healthcare Stocks According to Hedge Funds. In this article, we are going to ...

Critics, including Senator Bernie Sanders, question whether the push to block alternatives is truly about safety — or simply ...

Uptake of continuous glucose monitoring (CGM) was relatively low among vulnerable diabetes patients in the largest national ...

Social conservatives have not found much of a home in DONALD TRUMP ’s Cabinet — at least not in the vein of Focus on the ...

Novo Holdings is set to gain unconditional EU antitrust approval for its planned $16.5 billion takeover of U.S. contract drug ...

Despite the current downward trend of NVO, it is a good stock to retain in one's portfolio for long-term gains due to strong ...